Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
two referees through this form https://www.um.edu.mt/hrmd/workatum-projects by not later than Monday, 7th September 2026. Late applications will not be considered. Further information may be obtained
-
postdoctoral fellow will investigate the effects of novel immunotherapies in both in vitro and in vivo inflammatory models. They will contribute to antibody production and perform detailed structural and
-
(PLA2R1 and its fragments) in recombinant form. Produce monoclonal antibodies from patients in the form of mAb, Fab, and scFv. Characterize the molecular and functional properties of the interactions
-
at the department of Veterinary Biosciences is seeking a highly motivated Postdoctoral Scholar with expertise in viral research and antibody discovery to join our interdisciplinary team focused on understanding
-
genomics and transcriptomics, antibody development based on phage display, large-scale mass spectrometry-based proteomics, and associated bioinformatics. The department is also responsible for several
-
(NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), autoimmune encephalitis, and other neuroimmunologic disorders Deliver comprehensive outpatient and inpatient
-
. The Duke Laboratory for HIV-1 & COVID-19 Vaccine Research & Development is led by Drs. David Montefiori, PhD and Xiaoying (Shaunna) Shen, DVM, PhD. Our research focuses on neutralizing antibody
-
optimizing cell-based and biochemical assays for target validation; applying molecular biology techniques to characterize therapeutic antibodies and macromolecular drugs; conducting biostatistical analysis
-
suitable for the evaluation of biopharmaceuticals (antibodies, nanobodies, …) • Develop and validate protocols for the formation of multicellular liver organoids in microfluidic devices (hepatocytes, LSECs
-
multidisciplinary, NIH-funded research program at the interface of molecular imaging, antibody engineering, cancer biology, drug development, and translational oncology. Our laboratory develops next-generation